Holen Sie sich die Stockscreener-App
1.80
18.18%
-0.40
Vorhandelsmarkt:
1.81
0.01
+0.56%
Schlusskurs vom Vortag:
$2.20
Offen:
$2.18
24-Stunden-Volumen:
661.93K
Relative Volume:
1.14
Marktkapitalisierung:
$2.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.21M
KGV:
-32.85
EPS:
-0.0548
Netto-Cashflow:
-
1W Leistung:
-41.37%
1M Leistung:
-74.72%
6M Leistung:
-91.04%
1J Leistung:
-99.35%
1-Tages-Spanne:
$1.75
$2.1901
1-Wochen-Bereich:
$1.75
$2.8894
52-Wochen-Spanne:
$1.75
$392.00
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Firmenname
Conduit Pharmaceuticals Inc
Sektor
Branche
Telefon
(646) 491 9132
Adresse
4851 TAMIAMI TRAIL NORTH, NAPLES
Vergleichen Sie CDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDT
Conduit Pharmaceuticals Inc
|
1.80 | 2.77M | 0 | -4.21M | 0 | -0.0548 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.28 | 124.20B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
697.05 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
651.30 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.00 | 34.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.14 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Conduit Pharmaceuticals Inc Aktie (CDT) Neueste Nachrichten
Closing Bell Recap: Conduit Pharmaceuticals Inc (CDT) Ends at 1.80, Reflecting a -18.18 Downturn - The Dwinnex
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Declines By 67.6% - MarketBeat
Conduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary - Benzinga
Conduit Pharmaceuticals Inc (NASDAQ: CDT) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
Pre-Hour Trading Boosts Conduit (CDT) Following A Milestone - Stocks Telegraph
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence - The Manila Times
AI Breakthrough: How Conduit Pharma's Latest Tech Integration Could Revolutionize Drug Development Time - StockTitan
Stock market today: Nebius Group -30.94%, Conduit Pharmaceuticals -26.68% among biggest losers in early trading - Business Upturn
Conduit Pharmaceuticals to execute 1-for-100 reverse stock split - MSN
Conduit Pharmaceuticals enacts reverse stock split to meet Nasdaq standards - MSN
Conduit Pharmaceuticals Implements Reverse Stock Split Plan - TipRanks
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times
Conduit Pharmaceuticals Announces 1-for-100 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan
Conduit Pharmaceuticals Enters Strategic Agreement with Agility Life Sciences - Contract Pharma
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline - The Manila Times
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for - The Bakersfield Californian
Conduit Pharma Partners with Agility Life Sciences to Advance Autoimmune Drug Formulations - StockTitan
Conduit Pharmaceuticals secures stockholder approval By Investing.com - Investing.com Australia
Conduit Pharmaceuticals secures stockholder approval - Investing.com
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results - Benzinga
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December - Benzinga
Stock market today: IGM Biosciences plunged by 69.52% while XTI Aerospace down by 52.08% in early trading - Business Upturn
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today? - MSN
Presidio Property Trust Announces Series D Preferred Stock Cash Dividend - The Manila Times
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
Conduit Pharmaceuticals faces Nasdaq delisting over price, votes for reverse split - Investing.com India
Stock Plummets to Cents. Can the Company Bounce Back? - Jomfruland.net
Conduit Pharmaceuticals Faces Nasdaq Delisting, Plans Stock Split - TipRanks
Vela Technologies reports loss amid portfolio challenges By Investing.com - Investing.com Nigeria
Conduit Pharmaceuticals Leverages AI for Drug Development - Nasdaq
Conduit and Sarborg link to optimise AI drug development - MSN
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics - The Manila Times
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial - The Bakersfield Californian
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and - EIN News
Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule - The Manila Times
Conduit Pharmaceuticals files to sell 75M shares of common stock for holders - MSN
Conduit Pharmaceuticals issues convertible note, amends Nirland agreement - Investing.com
Conduit Pharmaceuticals issues convertible note, amends Nirland agreement By Investing.com - Investing.com Canada
What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga
Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - The Manila Times
Conduit Pharmaceuticals receives further patent approval for AZD1656 - TipRanks
Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve
Conduit Pharmaceuticals reshuffles board and amends bylaws - Investing.com
Finanzdaten der Conduit Pharmaceuticals Inc-Aktie (CDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.02%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):